Slowly eating into the sellers and going up on this milestone.
I am expecting the price to be much higher.
At least James is getting out there and trying to tell the world about PTX.
Prescient Therapeutics (ASX: PTX) is pleased to announce the first patient has been dosed in its Phase 2a clinical study of PTX-100.
This announcement, and its significance in advancing PTX-100 towards commercialisation, will be discussed in a live investor briefing on Thursday 29th May at 12pm (AEST). Register here or request a recording.
- Forums
- ASX - By Stock
- PTX
- Ann: First Patient dosed for PTX-100 Phase 2a Study
PTX
prescient therapeutics limited
Add to My Watchlist
4.08%
!
5.1¢

Ann: First Patient dosed for PTX-100 Phase 2a Study, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.1¢ |
Change
0.002(4.08%) |
Mkt cap ! $41.07M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.9¢ | $3.521K | 70.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 100000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10100 | 0.053 |
1 | 40000 | 0.051 |
1 | 40000 | 0.050 |
2 | 211415 | 0.049 |
1 | 416666 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 10099 | 1 |
0.053 | 100000 | 2 |
0.055 | 100000 | 1 |
0.056 | 57000 | 2 |
0.057 | 200000 | 1 |
Last trade - 15.59pm 17/06/2025 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online